Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited - Asset Resilience Ratio

Latest as of March 2026: 0.00%

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has an Asset Resilience Ratio of 0.00% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how liquid is Guangzhou Baiyunshan Pharmaceutical Hold's working capital to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

€4.00 Million
≈ $4.68 Million USD Cash + Short-term Investments

Total Assets

€89.76 Billion
≈ $104.94 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2015–2025)

This chart shows how Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Guangzhou Baiyunshan Pharmaceutical Hold total assets.

Liquid Assets Composition Over Time

This chart breaks down Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore GU5 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €4.00 Million 0.0%
Total Liquid Assets €4.00 Million 0.00%

Asset Resilience Insights

  • Limited Liquidity: Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited maintains only 0.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Industry Peers by Asset Resilience Ratio

Compare Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Sigma Healthcare Ltd
AU:SIG
Medical Distribution 0.03%
Selcuk Ecza Deposu Ticaret ve Sanayi AS
IS:SELEC
Medical Distribution 7.12%
Medios AG
XETRA:ILM1
Medical Distribution 0.08%
Ebos Group Ltd
AU:EBO
Medical Distribution 0.00%
Mayne Pharma Group Ltd
AU:MYX
Medical Distribution 4.00%
Paragon Care Ltd
AU:PGC
Medical Distribution 0.00%
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
Medical Distribution 4.48%
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
Medical Distribution 4.21%

Annual Asset Resilience Ratio for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2015–2025)

The table below shows the annual Asset Resilience Ratio data for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.00% €4.00 Million
≈ $4.68 Million
€84.51 Billion
≈ $98.80 Billion
0.00pp
2023-12-31 0.01% €4.00 Million
≈ $4.68 Million
€78.59 Billion
≈ $91.88 Billion
-0.07pp
2022-12-31 0.08% €56.87 Million
≈ $66.49 Million
€74.67 Billion
≈ $87.29 Billion
+0.07pp
2020-12-31 0.01% €4.00 Million
≈ $4.68 Million
€59.76 Billion
≈ $69.87 Billion
-2.99pp
2018-12-31 3.00% €1.54 Billion
≈ $1.80 Billion
€51.48 Billion
≈ $60.19 Billion
+2.98pp
2017-12-31 0.02% €4.88 Million
≈ $5.70 Million
€28.31 Billion
≈ $33.10 Billion
-0.01pp
2016-12-31 0.02% €6.03 Million
≈ $7.05 Million
€25.90 Billion
≈ $30.28 Billion
-0.25pp
2015-12-31 0.27% €43.19 Million
≈ $50.49 Million
€15.87 Billion
≈ $18.55 Billion
--
pp = percentage points

About Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

F:GU5 Germany Medical Distribution
Market Cap
$367.63 Million
€314.46 Million EUR
Market Cap Rank
#13963 Global
#1417 in Germany
Share Price
€1.43
Change (1 day)
+0.70%
52-Week Range
€1.42 - €2.30
All Time High
€2.30
About

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the pharmaceutical and healthcare industry in the People's Republic of China and internationally. The company operates through Modern Chinese Medicine Business, Chemical Pharmaceutical Technology Business, Natural Beverage Business, Pharmaceutical Commercial Business, and Other segments. It is involved in the research, develo… Read more